ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	10/38	95/10704	7.19553090731685e-13	1.13689388335606e-10	7.80147035214354e-11	PABPC1/RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	10
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	10/38	111/10704	3.53200731858615e-12	1.88348768115762e-10	1.29246656335267e-10	PABPC1/RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	10
R-HSA-927802	Nonsense-Mediated Decay (NMD)	10/38	115/10704	5.0593289229347e-12	1.88348768115762e-10	1.29246656335267e-10	PABPC1/RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	10
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	10/38	115/10704	5.0593289229347e-12	1.88348768115762e-10	1.29246656335267e-10	PABPC1/RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	10
R-HSA-72613	Eukaryotic Translation Initiation	10/38	119/10704	7.15248486515553e-12	1.88348768115762e-10	1.29246656335267e-10	PABPC1/RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	10
R-HSA-72737	Cap-dependent Translation Initiation	10/38	119/10704	7.15248486515553e-12	1.88348768115762e-10	1.29246656335267e-10	PABPC1/RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	10
R-HSA-156902	Peptide chain elongation	9/38	89/10704	1.6812678712511e-11	3.32050404572092e-10	2.27856040445873e-10	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-192823	Viral mRNA Translation	9/38	89/10704	1.6812678712511e-11	3.32050404572092e-10	2.27856040445873e-10	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-156842	Eukaryotic Translation Elongation	9/38	93/10704	2.51924250513154e-11	3.61854832555258e-10	2.4830811294598e-10	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-2408557	Selenocysteine synthesis	9/38	93/10704	2.51924250513154e-11	3.61854832555258e-10	2.4830811294598e-10	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-72764	Eukaryotic Translation Termination	9/38	93/10704	2.51924250513154e-11	3.61854832555258e-10	2.4830811294598e-10	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-72689	Formation of a pool of free 40S subunits	9/38	101/10704	5.36330171463554e-11	6.51847439163396e-10	4.47303705755028e-10	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-9633012	Response of EIF2AK4 (GCN2) to amino acid deficiency	9/38	101/10704	5.36330171463554e-11	6.51847439163396e-10	4.47303705755028e-10	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	9/38	112/10704	1.37349745990837e-10	1.44675065777015e-09	9.92773602600435e-10	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	9/38	112/10704	1.37349745990837e-10	1.44675065777015e-09	9.92773602600435e-10	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-2408522	Selenoamino acid metabolism	9/38	118/10704	2.20224250959155e-10	2.17471447822165e-09	1.49230906899953e-09	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-9010553	Regulation of expression of SLITs and ROBOs	10/38	171/10704	2.67282634278038e-10	2.48415624799588e-09	1.70465085638625e-09	PABPC1/RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	10
R-HSA-168273	Influenza Viral RNA Transcription and Replication	9/38	135/10704	7.38313169108408e-10	6.48074892884047e-09	4.44714949813836e-09	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-72649	Translation initiation complex formation	7/38	58/10704	1.04551122883053e-09	8.69425127132756e-09	5.96607515620745e-09	PABPC1/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	7
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	7/38	59/10704	1.18323860560397e-09	9.34758498427136e-09	6.41439875669521e-09	PABPC1/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	7
R-HSA-168255	Influenza Infection	9/38	156/10704	2.67375168430057e-09	2.01167983866424e-08	1.38043320041583e-08	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-376176	Signaling by ROBO receptors	10/38	218/10704	2.86964797035023e-09	2.06092899688789e-08	1.4142284255793e-08	PABPC1/RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	10
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	9/38	184/10704	1.14326236413772e-08	7.85371537103306e-08	5.38929169364694e-08	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-8868773	rRNA processing in the nucleus and cytosol	9/38	194/10704	1.81464533345799e-08	1.19464151119318e-07	8.19773988360408e-08	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	6/38	51/10704	2.12314505765779e-08	1.34182767643973e-07	9.2077448816317e-08	RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	6
R-HSA-72312	rRNA processing	9/38	204/10704	2.80920222174938e-08	1.70713058090924e-07	1.17144869975784e-07	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-72766	Translation	10/38	291/10704	4.55520493004987e-08	2.64456381660171e-07	1.81472400473002e-07	PABPC1/RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	10
R-HSA-72702	Ribosomal scanning and start codon recognition	6/38	58/10704	4.68656878891442e-08	2.64456381660171e-07	1.81472400473002e-07	RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	6
R-HSA-71291	Metabolism of amino acids and derivatives	9/38	374/10704	4.67708244337687e-06	2.54820353811567e-05	1.74860069570896e-05	RPL30/RPL32/RPLP0/RPS12/RPS17/RPS18/RPS2/RPS20/RPS6	9
R-HSA-1236977	Endosomal/Vacuolar pathway	3/38	11/10704	6.67920324977854e-06	3.51771371155003e-05	2.41388749027084e-05	B2M/HLA-A/HLA-B	3
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	3/38	25/10704	8.99611501848394e-05	0.00045851166868402	0.000314634922547995	B2M/HLA-A/HLA-B	3
R-HSA-6798695	Neutrophil degranulation	8/38	480/10704	0.000229494041023288	0.00113312682755248	0.000777562046888114	ANPEP/B2M/CTSD/HLA-A/HLA-B/HSP90AB1/LGALS3/PIGR	8
R-HSA-877300	Interferon gamma signaling	4/38	91/10704	0.000289279592501982	0.00138503562470646	0.000950424179512095	B2M/HLA-A/HLA-B/HLA-DRB1	4
R-HSA-6803157	Antimicrobial peptides	4/38	95/10704	0.000341094313340846	0.00158508533846628	0.0010877001323253	CHGA/PLA2G2A/REG3A/REG3G	4
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	2/38	10/10704	0.000542440046537478	0.00244872935294061	0.00168034059528903	B2M/HLA-A	2
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	2/38	18/10704	0.00181154642119176	0.00795067595967493	0.00545582694101611	ANPEP/CTSD	2
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	2/38	21/10704	0.00246980591274883	0.0105467387625491	0.00723726910421422	B2M/HLA-A	2
R-HSA-1236974	ER-Phagosome pathway	3/38	83/10704	0.00311873403866382	0.0129673678449706	0.00889832703552281	B2M/HLA-A/HLA-B	3
R-HSA-2980736	Peptide hormone metabolism	3/38	90/10704	0.00392020672385241	0.0158818631376585	0.0108982805008582	ANPEP/CTSD/GIP	3
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	2/38	28/10704	0.00437665349167602	0.0172877812921203	0.0118630344642797	B2M/HLA-A	2
R-HSA-1236975	Antigen processing-Cross presentation	3/38	98/10704	0.0049774110329707	0.0191812425173017	0.013162344965237	B2M/HLA-A/HLA-B	3
R-HSA-913531	Interferon Signaling	4/38	199/10704	0.00521923491076267	0.0196342646642977	0.0134732129275327	B2M/HLA-A/HLA-B/HLA-DRB1	4
R-HSA-2132295	MHC class II antigen presentation	3/38	123/10704	0.00931955106978417	0.0342439318378116	0.0234985008613897	CD74/CTSD/HLA-DRB1	3
R-HSA-6809371	Formation of the cornified envelope	3/38	130/10704	0.0108320631826452	0.0387503498755359	0.0265908463503011	KRT19/KRT20/KRT8	3
R-HSA-2172127	DAP12 interactions	2/38	45/10704	0.011036492053159	0.0387503498755359	0.0265908463503011	B2M/HLA-B	2
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	3/38	132/10704	0.0112888624556598	0.0387747884346574	0.0266076163142553	B2M/HLA-A/HLA-B	3
R-HSA-6790901	rRNA modification in the nucleus and cytosol	2/38	61/10704	0.0196886965596286	0.0661875331153472	0.0454184937433761	RPS2/RPS6	2
R-HSA-909733	Interferon alpha/beta signaling	2/38	70/10704	0.0254699497276316	0.0838385845201208	0.0575308074988171	HLA-A/HLA-B	2
R-HSA-6805567	Keratinization	3/38	214/10704	0.0398137351014259	0.128378982571945	0.0880948381406417	KRT19/KRT20/KRT8	3
R-HSA-3371511	HSF1 activation	1/38	12/10704	0.0417999264022099	0.132087767430983	0.0906398404090024	HSP90AB1	1
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	1/38	13/10704	0.0452054261026132	0.134763345739866	0.0924758468434789	GIP	1
R-HSA-75205	Dissolution of Fibrin Clot	1/38	13/10704	0.0452054261026132	0.134763345739866	0.0924758468434789	S100A10	1
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	1/38	13/10704	0.0452054261026132	0.134763345739866	0.0924758468434789	LGALS3	1
R-HSA-189483	Heme degradation	1/38	14/10704	0.0485991398626078	0.139612074514401	0.0958030891071503	FABP1	1
R-HSA-3371568	Attenuation phase	1/38	14/10704	0.0485991398626078	0.139612074514401	0.0958030891071503	HSP90AB1	1
R-HSA-844456	The NLRP3 inflammasome	1/38	15/10704	0.0519811073729185	0.146660981516449	0.100640113898696	HSP90AB1	1
R-HSA-399954	Sema3A PAK dependent Axon repulsion	1/38	16/10704	0.0553513681943072	0.15343010832808	0.105285150951314	HSP90AB1	1
R-HSA-1482922	Acyl chain remodelling of PI	1/38	17/10704	0.0587099617579881	0.159934033754519	0.109748204375187	PLA2G2A	1
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	1/38	18/10704	0.0620569273660349	0.166186347861585	0.114038599798423	GAST	1
R-HSA-1482925	Acyl chain remodelling of PG	1/38	19/10704	0.0653923041917966	0.166644904230708	0.114353265394823	PLA2G2A	1
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	1/38	19/10704	0.0653923041917966	0.166644904230708	0.114353265394823	HLA-DRB1	1
R-HSA-8876725	Protein methylation	1/38	19/10704	0.0653923041917966	0.166644904230708	0.114353265394823	RPS2	1
R-HSA-622312	Inflammasomes	1/38	20/10704	0.0687161312803053	0.170258967811568	0.116833269051243	HSP90AB1	1
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	1/38	22/10704	0.0753292917865515	0.170258967811568	0.116833269051243	HLA-DRB1	1
R-HSA-8935690	Digestion	1/38	22/10704	0.0753292917865515	0.170258967811568	0.116833269051243	LIPF	1
R-HSA-9613829	Chaperone Mediated Autophagy	1/38	22/10704	0.0753292917865515	0.170258967811568	0.116833269051243	HSP90AB1	1
R-HSA-162909	Host Interactions of HIV factors	2/38	130/10704	0.0775132824729156	0.170258967811568	0.116833269051243	B2M/HLA-A	2
R-HSA-1482801	Acyl chain remodelling of PS	1/38	23/10704	0.078618702656436	0.170258967811568	0.116833269051243	PLA2G2A	1
R-HSA-389948	PD-1 signaling	1/38	23/10704	0.078618702656436	0.170258967811568	0.116833269051243	HLA-DRB1	1
R-HSA-400508	Incretin synthesis, secretion, and inactivation	1/38	23/10704	0.078618702656436	0.170258967811568	0.116833269051243	GIP	1
R-HSA-163560	Triglyceride catabolism	1/38	24/10704	0.0818967186941721	0.170258967811568	0.116833269051243	FABP1	1
R-HSA-166208	mTORC1-mediated signalling	1/38	24/10704	0.0818967186941721	0.170258967811568	0.116833269051243	RPS6	1
R-HSA-3371571	HSF1-dependent transactivation	1/38	24/10704	0.0818967186941721	0.170258967811568	0.116833269051243	HSP90AB1	1
R-HSA-429947	Deadenylation of mRNA	1/38	24/10704	0.0818967186941721	0.170258967811568	0.116833269051243	PABPC1	1
R-HSA-9660826	Purinergic signaling in leishmaniasis infection	1/38	24/10704	0.0818967186941721	0.170258967811568	0.116833269051243	HSP90AB1	1
R-HSA-9664424	Cell recruitment (pro-inflammatory response)	1/38	24/10704	0.0818967186941721	0.170258967811568	0.116833269051243	HSP90AB1	1
R-HSA-189445	Metabolism of porphyrins	1/38	26/10704	0.0884187197854965	0.17910458623216	0.122903213736925	FABP1	1
R-HSA-6803529	FGFR2 alternative splicing	1/38	26/10704	0.0884187197854965	0.17910458623216	0.122903213736925	PTBP1	1
R-HSA-8963743	Digestion and absorption	1/38	27/10704	0.0916627812809214	0.18103399302982	0.124227190420196	LIPF	1
R-HSA-9635486	Infection with Mycobacterium tuberculosis	1/38	27/10704	0.0916627812809214	0.18103399302982	0.124227190420196	B2M	1
R-HSA-1482788	Acyl chain remodelling of PC	1/38	28/10704	0.0948956008286717	0.185104999147285	0.127020752246305	PLA2G2A	1
R-HSA-5683826	Surfactant metabolism	1/38	29/10704	0.0981172163371498	0.188279675037247	0.129199244029556	DMBT1	1
R-HSA-9018519	Estrogen-dependent gene expression	2/38	150/10704	0.0989064115701993	0.188279675037247	0.129199244029556	CTSD/HSP90AB1	2
R-HSA-1482839	Acyl chain remodelling of PE	1/38	30/10704	0.101327665590469	0.188350248979931	0.129247672517874	PLA2G2A	1
R-HSA-2424491	DAP12 signaling	1/38	30/10704	0.101327665590469	0.188350248979931	0.129247672517874	B2M	1
R-HSA-5339562	Uptake and actions of bacterial toxins	1/38	31/10704	0.104526986248851	0.192037951480446	0.131778207877988	HSP90AB1	1
R-HSA-420092	Glucagon-type ligand receptors	1/38	33/10704	0.110892391804574	0.201390780518652	0.138196205152706	GIP	1
R-HSA-202433	Generation of second messenger molecules	1/38	34/10704	0.114058551406432	0.20478694457064	0.140526684149073	HLA-DRB1	1
R-HSA-8979227	Triglyceride metabolism	1/38	37/10704	0.123491303166303	0.219231751688494	0.150438843597034	FABP1	1
R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	1/38	38/10704	0.126613767821753	0.2222775035093	0.15252886649872	RPLP0	1
R-HSA-1483166	Synthesis of PA	1/38	40/10704	0.132826238516672	0.230621381160814	0.158254512055722	PLA2G2A	1
R-HSA-165159	MTOR signalling	1/38	41/10704	0.135916317561717	0.233421501899471	0.160175980650537	RPS6	1
R-HSA-983169	Class I MHC mediated antigen processing & presentation	3/38	370/10704	0.142858318202037	0.242705529848621	0.166546765985396	B2M/HLA-A/HLA-B	3
R-HSA-69275	G2/M Transition	2/38	196/10704	0.153156905113141	0.256153804713469	0.175775095839356	HSP90AB1/MZT2B	2
R-HSA-9020591	Interleukin-12 signaling	1/38	47/10704	0.154232884469773	0.256153804713469	0.175775095839356	RPLP0	1
R-HSA-453274	Mitotic G2-G2/M phases	2/38	198/10704	0.155637754762614	0.256153804713469	0.175775095839356	HSP90AB1/MZT2B	2
R-HSA-191859	snRNP Assembly	1/38	53/10704	0.172171188923495	0.277582120917471	0.190479403427712	PHAX	1
R-HSA-194441	Metabolism of non-coding RNA	1/38	53/10704	0.172171188923495	0.277582120917471	0.190479403427712	PHAX	1
R-HSA-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR)	1/38	55/10704	0.178067884134524	0.280373904510161	0.192395150996313	HSP90AB1	1
R-HSA-429914	Deadenylation-dependent mRNA decay	1/38	55/10704	0.178067884134524	0.280373904510161	0.192395150996313	PABPC1	1
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	1/38	56/10704	0.181000875063521	0.280373904510161	0.192395150996313	HSP90AB1	1
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	1/38	56/10704	0.181000875063521	0.280373904510161	0.192395150996313	PABPC1	1
R-HSA-447115	Interleukin-12 family signaling	1/38	57/10704	0.18392367434485	0.282135345111517	0.193603867731421	RPLP0	1
R-HSA-8939211	ESR-mediated signaling	2/38	223/10704	0.187260003081953	0.284491158528351	0.195220448557096	CTSD/HSP90AB1	2
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	1/38	59/10704	0.189738835692598	0.285511771804099	0.195920802770301	HLA-A	1
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	1/38	61/10704	0.195513642503205	0.291425995429306	0.199979197396526	HSP90AB1	1
